Faculty Bibliography

STUDY OBJECTIVES: Patients with obstructive sleep apnea may have difficulty exhaling against positive pressure, hence limiting their acceptance of continuous positive airway pressure (CPAP). C-Flex is designed to improve comfort by reducing pressure in the mask during expiration proportionally to expiratory airflow (3 settings correspond to increasing pressure changes). When patients use CPAP, nasal resistance determines how much higher supraglottic pressure is than mask pressure. We hypothesized that increased nasal resistance results in increased expiratory supraglottic pressure swings that could be mitigated by the effects of C-Flex on mask pressure. DESIGN: Cohort study. SETTING: Sleep center. PARTICIPANTS: Seventeen patients with obstructive sleep apnea/hypopnea syndrome and a mechanical model of the upper airway. INTERVENTIONS: In patients on fixed CPAP, CPAP with different C-Flex levels was applied multiple times during the night. In the model, 2 different respiratory patterns and resistances were tested. MEASUREMENTS AND RESULTS: Airflow, expiratory mask, and supraglottic pressures were measured on CPAP and on C-Flex. Swings in pressure during expiration were determined. On CPAP, higher nasal resistance produced greater expiratory pressure swings in the supraglottis in the patients and in the model, as expected. C-Flex 3 produced expiratory drops in mask pressure (range -0.03 to -2.49 cm H(2)O) but mitigated the expira-tory pressure rise in the supraglottis only during a sinusoidal respiratory pattern in the model. CONCLUSIONS: Expiratory changes in mask pressure induced by C-Flex did not uniformly transmit to the supraglottis in either patients with obstructive sleep apnea on CPAP or in a mechanical model of the upper airway with fixed resistance. Data suggest that the observed lack of expiratory drop in supraglottic pressure swings is related to dynamics of the C-Flex algorithm. CITATION: Masdeu MJ; Patel AV; Seelall V; Rapoport DM; Ayappa I. The supraglottic effect of a reduction in expiratory mask pressure during continuous positive airway pressure. SLEEP 2012;35(2):263-272.

STUDY OBJECTIVES: Since on CPAP, the nose is the primary determinant of upper airway resistance, we assess utility of noninvasive measures of nasal resistance during wakefulness as a predictor of directly assessed upper airway resistance on CPAP during sleep in patients with obstructive sleep apnea/hypopnea syndrome. METHODS: Patients with complaints of snoring and excessive daytime sleepiness were recruited. 14 subjects underwent daytime evaluations including clinical assessment, subjective questionnaires to assess nasal symptoms and evaluation of nasal resistance with acoustic rhinometry (AR) and active anterior rhinomanometry (RM) in the sitting and supine positions. Patients underwent nocturnal polysomnography on optimal CPAP with measurements of supraglottic pressure to evaluate upper airway resistance. Comparisons were made between nasal resistance using AR and RM during wakefulness, and between AR and RM awake and upper airway resistance during sleep. RESULTS: Our study shows that measures of awake nasal resistance using AR and RM had little or no correlation to each other in the sitting position, whereas there was significant but weak correlation in the supine position. Upper airway resistance measured while on CPAP during sleep did not show significant relationships to any of the awake measures of nasal resistance (AR or RM). CONCLUSION: Awake measurements of nasal resistance do not seem to be predictive of upper airway resistance during sleep on CPAP

STUDY OBJECTIVES: To evaluate the validity of the Apnea Risk Evaluation System (ARES) Unicorder, a self-applied, limited-channel portable monitoring device for the evaluation of sleep disordered breathing (SDB). DESIGN: Prospective study with blinded analysis. SETTING: Sleep disorder center, academic institution. PARTICIPANTS: Eighty patients with suspected obstructive sleep apnea hypopnea syndrome (OSAHS) and 22 volunteers. INTERVENTIONS: N/A. MEASUREMENTS AND RESULTS: Subjects used the ARES Unicorder at home for 2 nights using only written instructions. Within 2 weeks, they returned to the laboratory for full nocturnal polysomnography (NPSG) with simultaneous monitoring with the Unicorder. NPSGs were scored manually to obtain an apnea-hypopnea index based on Medicare guidelines (AHI4%) and a respiratory disturbance index (RDI). ARES studies were autoscored and reviewed to obtain indices based on equivalent definitions i.e., AHI4%(ARES) and apnea hypopnea (events with 1% desaturation) index (AHI1%(ARES)). Indices from the NPSG were compared to the in-lab ARES and in-home ARES indices using mean differences and the intraclass correlations (ICC). For the in-lab comparison, there was high concordance between AHI4%(NPSG) and AHI4%(ARES) (ICC = 0. 96, mean difference = 0.5/hour) and RDI(NPSG ) and AHI1%(ARES) (ICC =0.93, mean difference = 3.2/hour). For NPSG versus In-Home ARES comparison, there was good concordance between AHI4%(NPSG) and AHI4%(ARES) (ICC = 0.8, mean difference = 4.1/ hour) and RDI(NPSG) and AHI1%(ARES) (ICC = 0.8 mean difference = 8.6/hour). The diagnostic sensitivity of in-lab ARES for diagnosing SDB using an RDI cut-off of 15 per hour was 95% and specificity was 94%, with a positive likelihood ratio (LR+) =17.04, and negative likelihood ratio (LR-) = 0.06. For in-home ARES data the sensitivity was 85% and specificity 91% (LR+ = 9.34, LR- = 0.17). There was good agreement between the manually scored NPSG SDB indices and the autoscoring ARES algorithm. CONCLUSIONS: ARES Unicorder provides acceptably accurate estimates of SDB indices compared to conventional laboratory NPSG for both the simultaneous and in-home ARES data. The high sensitivity, specificity, and positive and negative likelihood ratios obtained in the group we studied supports the utility of an ambulatory limited-monitoring approach not only for diagnosing sleep disordered breathing but also to rule out SDB in suitably selected groups.